Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Chinese Patent Office
Mallinckrodt
US Army
Fish and Richardson
Medtronic
Cerilliant
Federal Trade Commission

Generated: May 27, 2018

DrugPatentWatch Database Preview

PATHOCIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Pathocil patents expire, and when can generic versions of Pathocil launch?

Pathocil is a drug marketed by Wyeth Ayerst and is included in two NDAs.

The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
Summary for PATHOCIL
Drug patent expirations by year for PATHOCIL
Medical Subject Heading (MeSH) Categories for PATHOCIL
Synonyms for PATHOCIL
(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
116D765
13412-64-1 (mono-hydrochloride salt, mono-hydrate)
3-(2,6-Dichlorophenyl)-5-methyl-4-isooxazolylpenicillin
3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin
3116-76-5
343-55-5 (mono-hydrochloride salt, anhydrous)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-
6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid
6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid
AC1L2BXC
AC1Q5QXP
AJ-47565
AK115170
AKOS016010072
API0004676
AX8110166
BDBM50350476
BPBio1_000550
BRD-K05673000-323-02-8
BRL 1702
BSPBio_000500
BSPBio_002171
C-22698
C06950
CC-26562
CHEBI:4511
CHEMBL893
COF19H7WBK
D02348
D0R2KJ
DB00485
Dichloroxacillin
Diclocil (TN)
Diclossacillina
Diclossacillina [DCIT]
Dicloxaciclin
Dicloxacilin
Dicloxacilina
Dicloxacilina [INN-Spanish]
dicloxacillin
Dicloxacillin (USAN/INN)
Dicloxacillin [USAN:INN:BAN]
Dicloxacillin sodium
Dicloxacillin sodium hydrate
Dicloxacillin, Monosodium Salt, Mono-Hydrate
Dicloxacillina
Dicloxacilline
Dicloxacilline [INN-French]
Dicloxacillinum
Dicloxacillinum [INN-Latin]
Dicloxacycline
DivK1c_000658
DTXSID1022924
Dycill
Dynapen
EINECS 221-488-3
Epitope ID:181860
FT-0603629
HSDB 3222
IDI1_000658
KB-291399
KBio1_000658
KBio2_001412
KBio2_003980
KBio2_006548
KBio3_001391
KBioGR_001053
KBioSS_001412
LS-174329
Maclicine
Methyldichlorophenylisoxazolylpenicillin
NINDS_000658
NM|| Dicloxacillin
Prestwick0_000450
Prestwick1_000450
Prestwick2_000450
Prestwick3_000450
R-13423
SBI-0051342.P003
SCHEMBL23955
SPBio_001041
SPBio_002439
Spectrum_000932
Spectrum2_000981
Spectrum3_000386
Spectrum4_000507
Spectrum5_000869
UNII-COF19H7WBK
YFAGHNZHGGCZAX-JKIFEVAISA-N
ZINC3978006

US Patents and Regulatory Information for PATHOCIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst PATHOCIL dicloxacillin sodium CAPSULE;ORAL 050011-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst PATHOCIL dicloxacillin sodium CAPSULE;ORAL 050011-003 Mar 28, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst PATHOCIL dicloxacillin sodium FOR SUSPENSION;ORAL 050092-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald
Mallinckrodt
Fish and Richardson
Cerilliant
UBS
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.